These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2468860

  • 1. Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
    Faulhaber HD, Gruner R, Homuth V, Naumann E, Menz M, Hartrodt W, Schmidt J, Mohnike W.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S146-8. PubMed ID: 2468860
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
    Johnson BF, Romero L, Marwaha R.
    Clin Pharmacol Ther; 1986 Apr; 39(4):389-94. PubMed ID: 2937598
    [Abstract] [Full Text] [Related]

  • 3. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E, Distler A, Gotzen R, Thiede HM, Philipp T.
    J Cardiovasc Pharmacol; 1984 Apr; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy and safety of nitrendipine in severe essential hypertension.
    Burris JF, Nash DT, Mroczek WJ.
    J Cardiovasc Pharmacol; 1988 Apr; 12 Suppl 4():S157-60. PubMed ID: 2468863
    [Abstract] [Full Text] [Related]

  • 5. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E, Muiesan ML, Rizzoni D, Romanelli G, Beschi M, Castellano M.
    J Cardiovasc Pharmacol; 1991 Apr; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [Abstract] [Full Text] [Related]

  • 6. Prolonged calcium channel blocker therapy of hypertension.
    Weber MA.
    J Cardiovasc Pharmacol; 1988 Apr; 12 Suppl 4():S16-21. PubMed ID: 2468864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.
    Maltz MB, Davies DW, Lau CP, Creamer JE, Banim SO, Camm AJ.
    Br J Clin Pharmacol; 1986 Oct; 22(4):463-7. PubMed ID: 3533128
    [Abstract] [Full Text] [Related]

  • 14. Long-term antihypertensive effects and safety of nitrendipine in patients with mild, moderate, and severe hypertension.
    Kann J.
    J Clin Pharmacol; 1987 Dec; 27(12):945-50. PubMed ID: 3437066
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of a new calcium antagonist in severe hypertension.
    Burris JF, Santangelo RP, Mroczek WJ.
    J Clin Pharmacol; 1986 Dec; 26(8):593-7. PubMed ID: 3793949
    [Abstract] [Full Text] [Related]

  • 16. Similar efficacy of nitrendipine in young and elderly hypertensive patients.
    Mehta J, Lopez LM, Deedwania PC, Fagan TC, Sternlieb CM, Vlachakis ND, Birkett JP, Schwartz LA.
    Am J Cardiol; 1987 Nov 01; 60(13):1096-100. PubMed ID: 3314459
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment of essential arterial hypertension with nitrendipine.
    Uslenghi E, Minelli M, Bo L, Avogliero G, Amerio S, Rocci R, Borgnino C.
    Clin Ther; 1988 Nov 01; 10(2):169-77. PubMed ID: 3273864
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.